Page last updated: 2024-10-24

caffeine and Acute Myelogenous Leukemia

caffeine has been researched along with Acute Myelogenous Leukemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baska, F1
Sipos, A1
Őrfi, Z1
Nemes, Z1
Dobos, J1
Szántai-Kis, C1
Szabó, E1
Szénási, G1
Dézsi, L1
Hamar, P1
Cserepes, MT1
Tóvári, J1
Garamvölgyi, R1
Krekó, M1
Őrfi, L1
Gibbs, BF1
Gonçalves Silva, I1
Prokhorov, A1
Abooali, M1
Yasinska, IM1
Casely-Hayford, MA1
Berger, SM1
Fasler-Kan, E1
Sumbayev, VV1
Menegaux, F1
Ripert, M1
Hémon, D1
Clavel, J1
Efferth, T1
Fabry, U1
Glatte, P1
Osieka, R1

Other Studies

4 other studies available for caffeine and Acute Myelogenous Leukemia

ArticleYear
Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases.
    European journal of medicinal chemistry, 2019, Dec-15, Volume: 184

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug

2019
Caffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity.
    Oncotarget, 2015, Oct-06, Volume: 6, Issue:30

    Topics: Angiogenic Proteins; Basophils; Caffeine; Cell Line, Tumor; Cell Lineage; Cytokines; Dose-Response R

2015
Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French population-based case-control study.
    Paediatric and perinatal epidemiology, 2007, Volume: 21, Issue:4

    Topics: Adolescent; Alcohol Drinking; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Chi

2007
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.
    Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:11

    Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance,

1995